SynthesisBMC endocrine disorders2026

Efficacy and safety of orforglipron 12 mg versus orforglipron 36 mg maintenance dose among patients with obesity with or without diabetes: a systematic review and comprehensive meta-analysis.

Mohamed Gamal Hegaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.